Trial intelligence / Profile preview

LHRHa in Pubertal Patients With Extreme Short Stature

NCT00001190Phase 2Completed

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Nov 1983
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of deslorelin in short stature, dwarfism, growth disorder, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Nov 1983; status: completed.

02

Drugs

deslorelin
03

Conditions

short staturedwarfismgrowth disorder

Beyond the preview

Go deeper on NCT00001190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call